Evidence map›Paper›PMID 32576065›Full record

ArticleGut microbes2020

Serum metabolites reflecting gut microbiome alpha diversity predict type 2 diabetes.

Cristina Menni, Jialing Zhu, Caroline I Le Roy, Olatz Mompeo, Kristin Young, Casey M Rebholz, Elizabeth Selvin, Kari E North, Robert P Mohney, Jordana T Bell and 5 more

Open access · goldAbstract read
In one paragraph

Article in Gut microbes, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 80 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
80citing papers in PubMed, 1 pooled it
5.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

80 citing papers in PubMed, 1 synthesis or guideline pooled it, 125 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Magnesium and imidazole propionate.Clinical nutrition ESPEN · 2021
    Trial
  6. Trial
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Observational
  18. Review
  19. Review
  20. Article

20 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 7 institutions in 2 countries.

Cristina MenniDepartment of Twin Research and Genetic Epidemiology, Kings College London , London, UK.ORCID 0000-0001-9790-0571
Jialing ZhuSchool of Public Health, University of Texas Health Science Center , Houston, TX, USA.
Caroline I Le RoyDepartment of Twin Research and Genetic Epidemiology, Kings College London , London, UK.ORCID 0000-0002-0341-751X
Olatz MompeoDepartment of Twin Research and Genetic Epidemiology, Kings College London , London, UK.
Kristin YoungDepartment of Epidemiology, Gillings School of Global Public Health, University of North Carolina , Chapel Hill, NC, USA.ORCID 0000-0003-0070-6145
Casey M RebholzDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health , Baltimore, MD, USA.ORCID 0000-0002-5442-8745
Elizabeth SelvinDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health , Baltimore, MD, USA.ORCID 0000-0001-6923-7151
Kari E NorthDepartment of Epidemiology, Gillings School of Global Public Health, University of North Carolina , Chapel Hill, NC, USA.
Robert P MohneyMetabolon Inc ., Morrisville, NC, USA.ORCID 0000-0002-9315-9541
Jordana T BellDepartment of Twin Research and Genetic Epidemiology, Kings College London , London, UK.ORCID 0000-0002-3858-5986
Eric BoerwinkleSchool of Public Health, University of Texas Health Science Center , Houston, TX, USA.
Tim D SpectorDepartment of Twin Research and Genetic Epidemiology, Kings College London , London, UK.ORCID 0000-0002-9795-0365
Massimo ManginoDepartment of Twin Research and Genetic Epidemiology, Kings College London , London, UK.ORCID 0000-0002-2167-7470
Bing YuSchool of Public Health, University of Texas Health Science Center , Houston, TX, USA.ORCID 0000-0003-4818-1077
Ana M ValdesDepartment of Twin Research and Genetic Epidemiology, Kings College London , London, UK.ORCID 0000-0003-1141-4471
King's College London · GBJohns Hopkins University · USThe University of Texas Health Science Center at Houston · USUniversity of North Carolina at Chapel Hill · USBaylor College of Medicine · USMetabolon (United States) · USUniversity of Nottingham · GB

Funding

Metabolic Signatures Underlying Cardiac Function for Heart Failure in Multi-Ethnic PopulationsR01HL141824 · NHLBI · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI YU, BING · 2018 to 2021
$3.1M
Semiparametric Analysis of Big Censored DataR01HL149683 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI LIN, DANYU · 2020 to 2023
$1.9M
GWA for Gene-Environment Interaction Effects Influencing CHDU01HG004402 · NHGRI · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI BOERWINKLE, ERIC A. · 2007 to 2009
$1.6M
Statistical Methods in Trans-Omics Chronic Disease ResearchR01HG009974 · NHGRI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI LIN, DANYU · 2018 to 2022
$1.5M
Trans-omics Analysis to Unravel Molecular Underpinnings of Heart, Lung and Blood Disease Risk FactorsR01HL142003 · NHLBI · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI YU, BING · 2018 to 2019
$934k
Metabolomics for Identifying Biomarkers of Dietary Intake & Kidney Disease ProgressionK01DK107782 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI REBHOLZ, CASEY MARIE · 2016 to 2020
$778k
Research and Mentoring in the Clinical Epidemiology of Cardiovascular Disease and Type 2 DiabetesK24HL152440 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI SELVIN, ELIZABETH · 2020 to 2024
$612k
Dietary Biomarkers and Cardioprotective Mechanisms of the DASH-Sodium Diet.R21HL143089 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI REBHOLZ, CASEY MARIE · 2018 to 2019
$258k
British Heart Foundation SP/14/8/31352Department of HealthMedical Research Council MR/M004422/1Medical Research Council MR/M016560/1Medical Research Council MR/N01183X/1Medical Research Council MR/N030125/1NHGRI NIH HHS U01 HG004402NHLBI NIH HHS HHSN268201700001CNHLBI NIH HHS HHSN268201700001INHLBI NIH HHS HHSN268201700002CNHLBI NIH HHS HHSN268201700002INHLBI NIH HHS HHSN268201700003CNHLBI NIH HHS HHSN268201700003INHLBI NIH HHS HHSN268201700004CNHLBI NIH HHS HHSN268201700004INHLBI NIH HHS HHSN268201700005CNHLBI NIH HHS HHSN268201700005INHLBI NIH HHS R01 HL141824NHLBI NIH HHS R01 HL142003NHLBI NIH HHS R21 HL143089NIDDK NIH HHS K01 DK107782Wellcome Trust
6 · The paper itself

Abstract

Type 2 diabetes (T2D) is associated with reduced gut microbiome diversity, although the cause is unclear. Metabolites generated by gut microbes also appear to be causative factors in T2D. We therefore searched for serum metabolites predictive of gut microbiome diversity in 1018 females from TwinsUK with concurrent metabolomic profiling and microbiome composition. We generated a Microbial Metabolites Diversity (MMD) score of six circulating metabolites that explained over 18% of the variance in microbiome alpha diversity. Moreover, the MMD score was associated with a significantly lower odds of prevalent (OR[95%CI] = 0.22[0.07;0.70], P = .01) and incident T2D (HR[95%CI] = 0.31[0.11,0.90], P = .03). We replicated our results in 1522 individuals from the ARIC study (prevalent T2D: OR[95%CI] = 0.79[0.64,0.96], P = .02, incident T2D: HR[95%CI] = 0.87[0.79,0.95], P = .003). The MMD score mediated 28%[15%,94%] of the total effect of gut microbiome on T2D after adjusting for confounders. Metabolites predicting higher microbiome diversity included 3-phenylpropionate(hydrocinnamate), indolepropionate, cinnamoylglycine and 5-alpha-pregnan-3beta,20 alpha-diol monosulfate(2) of which indolepropionate and phenylpropionate have already been linked to lower incidence of T2D. Metabolites correlating with lower microbial diversity included glutarate and imidazole propionate, of which the latter has been implicated in insulin resistance. Our results suggest that the effect of gut microbiome diversity on T2D is largely mediated by microbial metabolites, which might be modifiable by diet.

Indexed as

Gastrointestinal MicrobiomeAgedBacteriaCohort StudiesDiabetes Mellitus, Type 2FemaleHumansMaleMetabolomicsMiddle AgedSerumincident diabetesMicrobial metabolitesmicrobiome diversityprevalent diabetes

Identifiers

PMID32576065
PMCPMC7524143
OpenAlexW3037733725

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.